FN1 and osteosarcoma: Previous studies showed that the various components of the ECM, including collagens, fibronectin, laminins, and proteoglycans, may contribute to osteosarcoma progression and metastasis through distinct and intertwining mechanisms, making them potential clinical biomarkers and therapeutic targets.